Cargando…
Personalizing vulvar cancer workflow in COVID-19 era: a proposal from Vul.Can MDT
INTRODUCTION: Since the community spread of Coronavirus disease 2019 (COVID-19), the practice of oncologic care at our comprehensive cancer center has changed. Postponing cancer treatment without consideration of its implications could cost more lives than can be saved. In this special situation, we...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354358/ https://www.ncbi.nlm.nih.gov/pubmed/32656663 http://dx.doi.org/10.1007/s00432-020-03312-9 |
_version_ | 1783558067968802816 |
---|---|
author | Garganese, Giorgia Tagliaferri, Luca Fragomeni, Simona Maria Lancellotta, Valentina Colloca, Giuseppe Corrado, Giacomo Gentileschi, Stefano Macchia, Gabriella Tamburrini, Enrica Gambacorta, Maria Antonietta Fagotti, Anna Scambia, Giovanni |
author_facet | Garganese, Giorgia Tagliaferri, Luca Fragomeni, Simona Maria Lancellotta, Valentina Colloca, Giuseppe Corrado, Giacomo Gentileschi, Stefano Macchia, Gabriella Tamburrini, Enrica Gambacorta, Maria Antonietta Fagotti, Anna Scambia, Giovanni |
author_sort | Garganese, Giorgia |
collection | PubMed |
description | INTRODUCTION: Since the community spread of Coronavirus disease 2019 (COVID-19), the practice of oncologic care at our comprehensive cancer center has changed. Postponing cancer treatment without consideration of its implications could cost more lives than can be saved. In this special situation, we must continue to provide our cancer patients with the highest quality of medical services assuring the safety. This article provides general guidance on supporting curative treatment strategies in vulvar cancer patients. METHODS: At our institution, a vulvar cancer multidisciplinary team (Vul.Can MDT) of specialists is responsible for personalized treatment of this disease. The phase 2 period necessarily requires specific procedures for both outpatient and inpatient pathways and to provide strategies concerning the management of vulvar cancer patients even in case of an eventually concomitant SARS-CoV-2 infection. In brief, an accurate remote and in person triage must be provided routinely and patients submitted to specific diagnostic tests prior to every major treatment or procedure (surgery, RT, and CT) or in case of suspicion for COVID-19 syndrome. The decisional workflow for these women often old and frail, have been rapidly adjusted by our Vul.Can MDT to mitigate the potential risks of COVID-19. RESULTS: The team produced two types of recommendations concerning: (1) safety regulations of care pathways, patients and health care providers, (2) personalized treatment strategies. We present a protocol that can be applied in clinical practice: the flowcharts provided, include the modulation of treatment intensity designed for surgical procedures and radiation, stratified for FIGO stage of disease and intention. CONCLUSION: We suggest that our proposals are applicable in this setting of patients, considering anyway current international recommendations and guidelines. |
format | Online Article Text |
id | pubmed-7354358 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-73543582020-07-13 Personalizing vulvar cancer workflow in COVID-19 era: a proposal from Vul.Can MDT Garganese, Giorgia Tagliaferri, Luca Fragomeni, Simona Maria Lancellotta, Valentina Colloca, Giuseppe Corrado, Giacomo Gentileschi, Stefano Macchia, Gabriella Tamburrini, Enrica Gambacorta, Maria Antonietta Fagotti, Anna Scambia, Giovanni J Cancer Res Clin Oncol Original Article – Cancer Research INTRODUCTION: Since the community spread of Coronavirus disease 2019 (COVID-19), the practice of oncologic care at our comprehensive cancer center has changed. Postponing cancer treatment without consideration of its implications could cost more lives than can be saved. In this special situation, we must continue to provide our cancer patients with the highest quality of medical services assuring the safety. This article provides general guidance on supporting curative treatment strategies in vulvar cancer patients. METHODS: At our institution, a vulvar cancer multidisciplinary team (Vul.Can MDT) of specialists is responsible for personalized treatment of this disease. The phase 2 period necessarily requires specific procedures for both outpatient and inpatient pathways and to provide strategies concerning the management of vulvar cancer patients even in case of an eventually concomitant SARS-CoV-2 infection. In brief, an accurate remote and in person triage must be provided routinely and patients submitted to specific diagnostic tests prior to every major treatment or procedure (surgery, RT, and CT) or in case of suspicion for COVID-19 syndrome. The decisional workflow for these women often old and frail, have been rapidly adjusted by our Vul.Can MDT to mitigate the potential risks of COVID-19. RESULTS: The team produced two types of recommendations concerning: (1) safety regulations of care pathways, patients and health care providers, (2) personalized treatment strategies. We present a protocol that can be applied in clinical practice: the flowcharts provided, include the modulation of treatment intensity designed for surgical procedures and radiation, stratified for FIGO stage of disease and intention. CONCLUSION: We suggest that our proposals are applicable in this setting of patients, considering anyway current international recommendations and guidelines. Springer Berlin Heidelberg 2020-07-12 2020 /pmc/articles/PMC7354358/ /pubmed/32656663 http://dx.doi.org/10.1007/s00432-020-03312-9 Text en © Springer-Verlag GmbH Germany, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Original Article – Cancer Research Garganese, Giorgia Tagliaferri, Luca Fragomeni, Simona Maria Lancellotta, Valentina Colloca, Giuseppe Corrado, Giacomo Gentileschi, Stefano Macchia, Gabriella Tamburrini, Enrica Gambacorta, Maria Antonietta Fagotti, Anna Scambia, Giovanni Personalizing vulvar cancer workflow in COVID-19 era: a proposal from Vul.Can MDT |
title | Personalizing vulvar cancer workflow in COVID-19 era: a proposal from Vul.Can MDT |
title_full | Personalizing vulvar cancer workflow in COVID-19 era: a proposal from Vul.Can MDT |
title_fullStr | Personalizing vulvar cancer workflow in COVID-19 era: a proposal from Vul.Can MDT |
title_full_unstemmed | Personalizing vulvar cancer workflow in COVID-19 era: a proposal from Vul.Can MDT |
title_short | Personalizing vulvar cancer workflow in COVID-19 era: a proposal from Vul.Can MDT |
title_sort | personalizing vulvar cancer workflow in covid-19 era: a proposal from vul.can mdt |
topic | Original Article – Cancer Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354358/ https://www.ncbi.nlm.nih.gov/pubmed/32656663 http://dx.doi.org/10.1007/s00432-020-03312-9 |
work_keys_str_mv | AT garganesegiorgia personalizingvulvarcancerworkflowincovid19eraaproposalfromvulcanmdt AT tagliaferriluca personalizingvulvarcancerworkflowincovid19eraaproposalfromvulcanmdt AT fragomenisimonamaria personalizingvulvarcancerworkflowincovid19eraaproposalfromvulcanmdt AT lancellottavalentina personalizingvulvarcancerworkflowincovid19eraaproposalfromvulcanmdt AT collocagiuseppe personalizingvulvarcancerworkflowincovid19eraaproposalfromvulcanmdt AT corradogiacomo personalizingvulvarcancerworkflowincovid19eraaproposalfromvulcanmdt AT gentileschistefano personalizingvulvarcancerworkflowincovid19eraaproposalfromvulcanmdt AT macchiagabriella personalizingvulvarcancerworkflowincovid19eraaproposalfromvulcanmdt AT tamburrinienrica personalizingvulvarcancerworkflowincovid19eraaproposalfromvulcanmdt AT gambacortamariaantonietta personalizingvulvarcancerworkflowincovid19eraaproposalfromvulcanmdt AT fagottianna personalizingvulvarcancerworkflowincovid19eraaproposalfromvulcanmdt AT scambiagiovanni personalizingvulvarcancerworkflowincovid19eraaproposalfromvulcanmdt AT personalizingvulvarcancerworkflowincovid19eraaproposalfromvulcanmdt |